← FDA Drug Approvals (Drugs@FDA)

RANOLAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ARTHUR GRP · Approved 2020-03-23

Drug application

FDA Application #

ANDA212781

Application type

Abbreviated New Drug Application (Generic)

Brand name

RANOLAZINE

Generic name

RANOLAZINE

Active ingredients

RANOLAZINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ARTHUR GRP

Manufacturer

SunGen Pharma LLC

First approval

2020-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown